Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | 1,2-DG(38:3) | Lipid-depleted/compactin | 0.0 | BCD100322A02 | 2.3 | pmol/sample |
| - | 1,2-DG(38:3) | Lipid-depleted/compactin | 0.5 | BCD100322A05 | 2.48 | pmol/sample |
| - | 1,2-DG(38:3) | Lipid-depleted/compactin | 1.0 | BCD100322A09 | 2.35 | pmol/sample |
| - | 1,2-DG(38:3) | Lipid-depleted/compactin | 2.0 | BCD100322A13 | 2.58 | pmol/sample |
| - | 1,2-DG(38:3) | Lipid-depleted/compactin | 4.0 | BCD100322A17 | 3.42 | pmol/sample |
| - | 1,2-DG(38:3) | Lipid-depleted/compactin | 8.0 | BCD100322A21 | 2.81 | pmol/sample |
| - | 1,2-DG(38:3) | Lipid-depleted/compactin | 12.0 | BCD100322A25 | 3.97 | pmol/sample |
| - | 1,2-DG(38:3) | Lipid-depleted/compactin | 24.0 | BCD100322A29 | 5.8 | pmol/sample |
| - | 1,2-DG(38:3) | C | 0.0 | BCD100322A01 | 1.93 | pmol/sample |
| - | 1,2-DG(38:3) | C | 0.5 | BCD100322A03 | 2.18 | pmol/sample |
| - | 1,2-DG(38:3) | C | 1.0 | BCD100322A07 | 1.96 | pmol/sample |
| - | 1,2-DG(38:3) | C | 2.0 | BCD100322A11 | 2.91 | pmol/sample |
| - | 1,2-DG(38:3) | C | 4.0 | BCD100322A15 | 2.55 | pmol/sample |
| - | 1,2-DG(38:3) | C | 8.0 | BCD100322A19 | 3.17 | pmol/sample |
| - | 1,2-DG(38:3) | C | 12.0 | BCD100322A23 | 2.6 | pmol/sample |
| - | 1,2-DG(38:3) | C | 24.0 | BCD100322A27 | 2.09 | pmol/sample |
| - | 1,2-DG(38:3) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A06 | 2.17 | pmol/sample |
| - | 1,2-DG(38:3) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A10 | 3.74 | pmol/sample |
| - | 1,2-DG(38:3) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A14 | 2.13 | pmol/sample |
| - | 1,2-DG(38:3) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A18 | 2.77 | pmol/sample |
| - | 1,2-DG(38:3) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A22 | 3.12 | pmol/sample |
| - | 1,2-DG(38:3) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A26 | 2.88 | pmol/sample |
| - | 1,2-DG(38:3) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A30 | 2.97 | pmol/sample |
| - | 1,2-DG(38:3) | 25OH-Chol | 0.5 | BCD100322A04 | 2.23 | pmol/sample |
| - | 1,2-DG(38:3) | 25OH-Chol | 1.0 | BCD100322A08 | 2.47 | pmol/sample |
| - | 1,2-DG(38:3) | 25OH-Chol | 2.0 | BCD100322A12 | 1.74 | pmol/sample |
| - | 1,2-DG(38:3) | 25OH-Chol | 4.0 | BCD100322A16 | 1.67 | pmol/sample |
| - | 1,2-DG(38:3) | 25OH-Chol | 8.0 | BCD100322A20 | 2.26 | pmol/sample |
| - | 1,2-DG(38:3) | 25OH-Chol | 12.0 | BCD100322A24 | 2.35 | pmol/sample |
| - | 1,2-DG(38:3) | 25OH-Chol | 24.0 | BCD100322A28 | 1.26 | pmol/sample |